CN Bio develop applications for DMPK, toxicology and disease modelling (e.g. HBV, fatty liver disease) using PhysioMimix technology.
WEBINAR: Bridging the gap: using organ-on-a-chip as an experimental tool to develop (cost) effective therapeutics – Tuesday, 26 September 2023
